Metraipolis › archive › dc_eb2a47612474
CEACAM6 as a machine learning derived immune biomarker for predicting neoadjuvant chemotherapy response in HR+/HER2- breast cancer — Europe PMC PMID:40936892
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40936892
- DOI
- 10.3389/fimmu.2025.1662004
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-09T23:06:56.303Z
- SHA-256 of the archived text
3ff75622443071a17de26488b46fab54b212c7ef5ebcdb5e3e83384ccfacfeb3- Stable URL of this page
https://metraipolis.com/documento/dc_eb2a47612474
How to cite
CEACAM6 as a machine learning derived immune biomarker for predicting neoadjuvant chemotherapy response in HR+/HER2- breast cancer — Europe PMC PMID:40936892 — Europe PMC (en), https://europepmc.org/article/MED/40936892 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb2a47612474 (Metraipolis archive dc_eb2a47612474, sha256 3ff75622443071a17de26488b46fab54b212c7ef5ebcdb5e3e83384ccfacfeb3)
BibTeX
@misc{dceb2a47612474,
title = {CEACAM6 as a machine learning derived immune biomarker for predicting neoadjuvant chemotherapy response in HR+/HER2- breast cancer — Europe PMC PMID:40936892},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40936892},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb2a47612474; sha256 3ff75622443071a17de26488b46fab54b212c7ef5ebcdb5e3e83384ccfacfeb3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40936892. Agents can read the archived copy with the MCP tool read_document.